Imexpharm’s sustainability efforts recognized at CSA 2025 Imexpharm earns CSA 2025 recognition for advancing sustainable pharma practices through ESG, innovation, and community-focused initiatives. 08:00 18/07/2025
Vietnam Today Essential semiconductor chips expected to be designed, manufactured, and tested by Vietnam no later than 2027
